214 related articles for article (PubMed ID: 23807780)
1. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry.
Rowan DJ; Allende DS; Bellizzi AM; Gill RM; Liu X; McKenzie CA; Moreira RK; Mounajjed T; Said S; Westerhoff M; Jenkins SM; Batts KP; Burgart LJ; Lamps LW; Graham RP
Histopathology; 2021 Nov; 79(5):791-800. PubMed ID: 34080211
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical pitfalls in the diagnosis of hepatocellular adenomas and focal nodular hyperplasia: accurate understanding of diverse staining patterns is essential for diagnosis and risk assessment.
Kakar S; Torbenson M; Jain D; Wu TT; Yeh M; Ferrell LD
Mod Pathol; 2015 Jan; 28(1):159-60. PubMed ID: 25560413
[No Abstract] [Full Text] [Related]
4. Immunohistochemical pitfalls in the diagnosis of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Bioulac-Sage P; Sempoux C; Balabaud C
Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):245-9. PubMed ID: 24525010
[No Abstract] [Full Text] [Related]
5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
[TBL] [Abstract][Full Text] [Related]
7. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
Shafizadeh N; Kakar S
Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
[TBL] [Abstract][Full Text] [Related]
10. Glutamine Synthetase Immunoreactivity in Peritumoral Hyperplasia in Liver: Case Report of a Metastatic Paraganglioma With Focal Nodular Hyperplasia-Like Changes and Review of an Additional 54 Liver Masses.
Bryant BH; Zenali MJ; Swanson PE; Upton MP; Yeh MM; Cuevas C; Park JO; Westerhoff M
Am J Clin Pathol; 2016 Aug; 146(2):254-61. PubMed ID: 27247379
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.
Tsai JH; Jeng YM; Pan CC; Lu SW; Kuo YJ
Pathology; 2012 Dec; 44(7):605-10. PubMed ID: 22990279
[TBL] [Abstract][Full Text] [Related]
12. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
[TBL] [Abstract][Full Text] [Related]
13. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.
Bioulac-Sage P; Laumonier H; Rullier A; Cubel G; Laurent C; Zucman-Rossi J; Balabaud C
Liver Int; 2009 Mar; 29(3):459-65. PubMed ID: 18803590
[TBL] [Abstract][Full Text] [Related]
17. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
19. CRP Versus SAA for Identification of Inflammatory Hepatic Adenomas.
Soon GST; Yasir S; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson MS; Chen ZE
Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):590-595. PubMed ID: 37698958
[TBL] [Abstract][Full Text] [Related]
20. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]